|
Innogenetics NV - Comparative Business Analysis Snapshot
Business Description
Innogenetics NV. The Group's principal activities are to provide diagnostic and therapeutic products using biotechnological research. The Diagnostics business focuses on infectious diseases, genetic testing, and neurodegeneration of many common diseases like HIV, Syphilis, Mycobacteria, Alzheimer's disease, HLA Class I and II etc. The Therapeutics division develops vaccines for infectious diseases for which current treatment options are limited. Their products include vaccines for Hepatitis B, Hepatitis C, Pulmonary Edema and other hard-to-heal wounds. The Group has operations in the United States, Germany, Spain, Italy, France, Brazil and the United Kingdom.
Competitor Analysis
This analysis compares Innogenetics NV with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
